Kaye Daniel G 4
4 · CME GROUP INC. · Filed Jun 29, 2026
Research Summary
AI-generated summary of this filing
CME Group Director Daniel G. Kaye Receives Award of 645 Shares
What Happened
Daniel G. Kaye, a non-employee director of CME Group Inc. (CME), was issued 645 shares of Class A Common Stock on 2026-06-25 as an equity award. The per-share price reported for the award is $225.00, giving the award a total value of $145,125. This was an award/acquisition (code A), not a market purchase or sale.
Key Details
- Transaction date: 2026-06-25; Report filed: 2026-06-29 (Accession 0001556974-26-000005).
- Shares awarded: 645 Class A shares at $225.00 per share; total value $145,125.
- Footnote: Shares were granted under the CME Group Director Stock Plan and are fully vested with no vesting conditions.
- Post-transaction ownership: Not specified in the provided filing data.
- No indication in the provided data that the filing was late.
Context
This award is part of routine annual equity compensation for non-employee directors and represents compensation rather than a personal cash purchase or sale. Fully vested stock awards increase insider ownership but are standard director pay and do not, by themselves, imply a change in the director's view of the company.
Insider Transaction Report
- Award
Common Stock Class A
[F1]2026-06-25$225.00/sh+645$145,125→ 4,845 total
Footnotes (1)
- [F1]Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.